Down syndrome | Fetal DNA test - Ninalia NIPT

NIPT by Biomnis The new prenatal trisomy screening test based on maternal blood sample

Download the brochure

high risk pregnancy

Biomnis: A European Leader in Non-Invasive Genetic Screening Tests

Eurofins Biomnis is a European leader in the sector of specialized medical pathology, offering a large range of innovative genetic screening tests. The group has developed non-invasive testing kits that deliver fast and remarkably accurate results, detecting pathologies and disorders such as Down Syndrome, Patau Syndrome and Edwards' Syndrome through fetal and maternal cell-free DNA sampling.  Through a NIPT test, it can be determined whether the risk of fetal defects is high or low, reducing invasive procedures by up to 95%.

Prescribing a non-invasive prenatal screening method for the detection of common trisomies and fetal anomalies offers reliable initial risk assessment for common abnormalities. With detection rates exceeding 99%, NIPT screening is generally recommended for mothers with risks greater than 1 in 1,000 according to serum markers. A positive result indicates a strong suspicion that anomalies relating to one or more genetic conditions are present. Available starting at 10 weeks of pregnancy, the test provides remarkably accurate screening from the first trimester of pregnancy. Eurofins Biomnis follows the international recommendations of the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM).

Advantages of NIPT by Biomnis

> 99 % Detection rateof NIPT test 1 Single blood sample 10 Available from week 10of amenorrhoea 7 Results availablewithin 7 working days 95 % Can minimize unnecessary invasive sampling by 95%
Related terms: pregnancy risk, prenatal down syndrome screening test, down syndrome blood testing, trisomy, trisomy 13, trisomy 18, trisomy 21, prenatal trisomy syndrome screening test, trisomy syndrome screening test, down syndrome, down syndrome screening test, prenatal genetic syndrome screening test, patau syndrome, can patau syndrome be prevented, patau syndrome quad screen, edwards syndrome, can edwards syndrome be prevented, edwards syndrome quad screen, sex aneuploidy, NIPT, fetal diagnosis, amniocentesis test, cell free fetal dna, fetal dna test, triple test, non invasive genetic testing, high risk pregnancy, patau syndrome genome, test for trisomy 21, early genetic testing, gender determination test, prenatal screening test, prenatal blood tests, fetal testing, prenatal testing of trisomy, genetic disease testing, genetic screening test, diagnosis neural tube, prenatal screening.